Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Neil Stahl
Age : 64
Public asset : 36,731,127 USD
Country of residence : Unknown
Linked companies : Regeneron Pharmaceuticals, Inc.

Biography of Neil Stahl 
Neil Stahl is Executive VP-Research & Development at Regeneron Pharmaceuticals, Inc. Dr. Stahl previously held the position of Member of The University of California, San Francisco. Dr. Stahl received a doctorate from Brandeis University and an undergraduate degree from Duke University.


Current positions of Neil Stahl 
Holdings of Neil Stahl 
Neil Stahl : Personal Network 
Most Read News 
09/28Buffett's Berkshire Hathaway buys 5.99 million more Occidental shares
RE
09/26Unilever's soap opera: M&A, Nelson Peltz, CEO to retire
RE
10/04Musk says Twitter deal is 'accelerant' to creating 'everything app'
RE
09/26Twitter to interview Elon Musk, known for combative testimony
RE
09/21Trump ally Barrack's trial on foreign agent charges moves to opening statements
RE
09/28Elon Musk seeks to narrow SEC consent decree, end pre-approval of tweets
RE
09/29The long, winding road to Volkswagen's Porsche IPO
RE
09/21Bloomberg to spend $85 million against U.S. plastic, petrochem buildout
RE
09/21Samsung Elec's Lee says SoftBank's Son expected to visit Seoul -media
RE
09/30Elon Musk set to showcase Tesla's humanoid robot after delay
RE
More news


© 2022 People and Ownership :   
Neil Stahl : Connections 


Latest news about Neil Stahl 
08/09Insider Sell: Regeneron Pharmaceuticals
MT
03/08Transcript : Regeneron Pharmaceuticals, Inc. Presents at 42nd Annual Cowen Health Care Conference, Mar-08-2022 01:30 PM
CI
2021Transcript : Regeneron Pharmaceuticals, Inc. Presents at 4th Annual Evercore ISI HealthCONx Virtual Conference, Nov-30-2021 09:15 AM
CI
2021Transcript : Regeneron Pharmaceuticals, Inc. Presents at BMO Biopharma Day: Spotlight on Rare Disease and Ophthalmology, Jun-22-2021 08:00 AM
CI
2021Transcript : Regeneron Pharmaceuticals, Inc. Presents at RBC Capital Markets 2021 Global Healthcare Conference, May-18-2021 08:00 AM
CI
2021Transcript : Regeneron Pharmaceuticals, Inc. Presents at Cowen 41st Annual Health Care Conference, Mar-02-2021 09:10 AM
CI
2020Transcript : Regeneron Pharmaceuticals, Inc. Presents at Citi 15th Annual Biopharma Virtual Conference 2020, Sep-09-2020 08:55 AM
CI
More news